[1] Marchetti P, Lupi R, Guerra SD, et al. The β-Cell in Human Type 2 Diabetes[J]. Adv Exp Med Biol, 2010, 654:501-514. [2] Campbell-Thompson M, Fu A, Kaddis JS, et al. Insulitis and beta-cell mass in the natural history of type 1 diabetes[J]. Diabetes, 2016, 65:719-731. [3] Kimura T, Obata A, Shimoda M, et al. Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure[J]. Diabetes Metab, 2018, 44:250-260. [4] Son DO, Liu WJ, Li XM, et al. Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic β-cell line and isolated human islets[J]. J Diabetes, 2019, 11:563-572. [5] Shu L, Matveyenko AV, Kerr-Conte J, et al. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function[J]. Hum Mol Genet, 2009, 18:2388-2399. [6] Filios SR, Xu G, Chen J, et al. miRNA-200 is induced by thioredoxin-interacting protein and regulates zeb1 protein signaling and beta cell apoptosis[J]. J Biol Chem, 2014, 289:275-283. [7] Zhang P, Gao J, Wang X, et al. A novel indication of thioredoxin-interacting protein as a tumor suppressor gene in malignant glioma[J]. Oncol lett, 2017, 14:2053-2058. [8] Xu G, Chen J, Jing G, et al. Thioredoxin-interacting protein regulates insulin transcription through miR-204[J]. Nat Med, 2013, 19:1141-1146. [9] Wang H, Brun T, Kataoka K, et al. MAFA controls genes implicated in insulin biosynthesis and secretion[J]. Diabetologia, 2007, 50:348-358. [10] Kawamori D, Shirakawa J, Liew CW, et al. GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice[J]. Diabetologia, 2017, 60:1442-1453. [11] Manabu K, Katsuya T, Kikuko AS, et al. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome[J]. Diabetologia, 2018, 61:2189-2201. |